<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04544865</url>
  </required_header>
  <id_info>
    <org_study_id>ESC_2018_03</org_study_id>
    <nct_id>NCT04544865</nct_id>
  </id_info>
  <brief_title>Study of ECHELON ENDOPATH(TM) Staple Line Reinforcement</brief_title>
  <official_title>A Prospective, Single-Arm, Multi-Center Study of the ECHELON ENDOPATH(TM) Staple Line Reinforcement Device in Gastric and Lung Resection Procedures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ethicon Endo-Surgery</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ethicon Endo-Surgery</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This prospective, single-arm, multi-center evaluation will collect clinical data in a&#xD;
      post-market setting. The two types of procedures studied will be gastric and thoracic.&#xD;
      Investigators will perform each procedure using the device in compliance with their standard&#xD;
      surgical approach and the ECHELON ENDOPATH Staple Line Reinforcement instructions for use.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of this study is to prospectively generate clinical data on&#xD;
      device-related adverse events in a post-market setting using ECHELON ENDOPATH Staple Line&#xD;
      Reinforcement per its instructions for use. There will be no blinding in this study. An&#xD;
      interim analysis is planned for sample-size re-estimation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 29, 2020</start_date>
  <completion_date type="Anticipated">August 26, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 3, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of device-related adverse events (AEs) in gastric procedures</measure>
    <time_frame>70 days (+/- 14 days) post-operative</time_frame>
    <description>Specific device-related AEs that will be captured and counted toward the primary endpoint for gastric procedures are:&#xD;
Bleeding: Occurrence of post-operative blood transfusion deemed related to bleeding at the staple line or return to operating room before 70-day post-procedure follow-up visit due to bleeding deemed related to the staple line; Leak: Occurrence of intra-operative or post-operative gastrointestinal leak related to the staple line as documented intra-operatively, by clinical exam, or radiographically; Stricture: Occurrence of stricture documented radiographically or by endoscopy along the staple line</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of device-related adverse events (AEs) in lung resection procedures</measure>
    <time_frame>70 days (+/- 14 days) post-operative</time_frame>
    <description>Specific device-related AEs that will be captured and counted toward the primary endpoint for lung resection procedures are:&#xD;
Prolonged air leak greater than postoperative day 7 deemed related to the staple line; Empyema: Purulent fluid collection in the pleural space documented radiographically, excluding chronic empyema</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Devices replaced during surgery due to slipping, bunching, or improper loading</measure>
    <time_frame>Intra-operative</time_frame>
    <description>Number of study devices replaced during surgery due to slipping, bunching, or not properly loaded onto stapler cartridge</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">243</enrollment>
  <condition>Gastric Procedures</condition>
  <condition>Lung Resection Procedures</condition>
  <arm_group>
    <arm_group_label>Gastric and thoracic staple line reinforcement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ECHELON ENDOPATH Staple Line Reinforcement is used during a gastric or thoracic procedure.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Staple Line Reinforcement</intervention_name>
    <description>ENDOPATH ECHELON Staple Line Reinforcement is used for reinforcement of staple lines during lung resection and bariatric surgical procedures, according to instructions for use.</description>
    <arm_group_label>Gastric and thoracic staple line reinforcement</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Primary procedure (gastric or lung resection) where the ECHELON SLR is planned to be&#xD;
             used for reinforcement of staple lines per the IFU in either a or b:&#xD;
&#xD;
               1. Gastric procedures limited to laparoscopic gastric resection, robotic&#xD;
                  laparoscopic gastric resection, partial gastrectomy, gastric wedge resection,&#xD;
                  subtotal gastrectomy, laparoscopic Roux-en-Y gastric bypass, and robotic&#xD;
                  laparoscopic gastric bypass; or&#xD;
&#xD;
               2. Lung resection procedures that include lobectomy, segmentectomy or wedge&#xD;
                  resection, and lung volume reduction surgery, and may be video assisted thoracic&#xD;
                  surgery (VATS) or open procedures;&#xD;
&#xD;
          -  Willingness to give consent and comply with all study-related evaluations and visit&#xD;
             schedule; and&#xD;
&#xD;
          -  At least 18 years of age.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - Preoperative:&#xD;
&#xD;
          1. Physical or psychological condition which would impair study participation;&#xD;
&#xD;
          2. Body mass index (BMI) ≥ 46.0 kg/m2;&#xD;
&#xD;
          3. The procedure is a revision/reoperation for the same indication or same anatomical&#xD;
             location;&#xD;
&#xD;
          4. A procedure where extended wound or organ support is required;&#xD;
&#xD;
          5. Any medical condition that the investigator deems could impact inflammatory or immune&#xD;
             response;&#xD;
&#xD;
          6. Concurrent treatment with medications that the investigator deems could have influence&#xD;
             on wound healing;&#xD;
&#xD;
          7. History of hypersensitivity to polyglactin (Vicryl®), Polydioxanone (PDO or PDS), or&#xD;
             hypersensitivity to related products (cross-allergy); or&#xD;
&#xD;
          8. Enrollment in a concurrent interventional clinical study that could impact the study&#xD;
             endpoints.&#xD;
&#xD;
               -  Intraoperative:&#xD;
&#xD;
          9. Per surgeon discretion, presence of adhesions that could lead to an increased risk of&#xD;
             leak occurrence at a different location than the staple line.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrew Popoff, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Henry Ford Health System</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David Zeltsman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Long Island Jewish Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Andrew Wheeler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Missouri-Columbia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jon Schram, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Spectrum Health Hospitals</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kenneth Kesler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Indiana University Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Emily Cassidy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Our Lady of the Lake Regional Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Keith Gersin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Atrium Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Elizabeth Myers</last_name>
    <phone>5138184219</phone>
    <email>emyers5@its.jnj.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Indiana University Health</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maryanne Bowyer-Cherry, RN</last_name>
      <email>mbowyer@iupui.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Our Lady of the Lake Regional Medical Center</name>
      <address>
        <city>Baton Rouge</city>
        <state>Louisiana</state>
        <zip>70808</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie Doyle</last_name>
      <email>Julie.Doyle@fmolhs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Henry Ford Health System</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lillian Hayes</last_name>
      <email>LHAYES4@hfhs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Spectrum Health</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49503</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pamela Merrill, RN</last_name>
      <email>pamela.merrill@spectrumhealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Missouri</name>
      <address>
        <city>Columbia</city>
        <state>Missouri</state>
        <zip>65201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Brown</last_name>
      <email>brownsarah@health.missouri.edu</email>
    </contact>
    <investigator>
      <last_name>Andrew Wheeler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Long Island Jewish Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>11040</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Efstathia Mihelis</last_name>
      <email>EMihelis@northwell.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Atrium Health</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katheryn Peterson</last_name>
      <email>Katheryn.Peterson@atriumhealth.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>September 4, 2020</study_first_submitted>
  <study_first_submitted_qc>September 4, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 10, 2020</study_first_posted>
  <last_update_submitted>November 1, 2021</last_update_submitted>
  <last_update_submitted_qc>November 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Buttress, gastrectomy, gastric bypass, lung volume reduction</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Johnson &amp; Johnson Medical Device Companies have an agreement with the Yale Open Data Access (YODA) Project to serve as the independent review panel for evaluation of requests for clinical study reports and participant level data from investigators and physicians for scientific research that will advance medical knowledge and public health. Requests for access to the study data can be submitted through the YODA Project site at http://yoda.yale.edu.</ipd_description>
    <ipd_url>http://yoda.yale.edu</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

